PL2337567T3 - Preparat weterynaryjny - Google Patents

Preparat weterynaryjny

Info

Publication number
PL2337567T3
PL2337567T3 PL09788414T PL09788414T PL2337567T3 PL 2337567 T3 PL2337567 T3 PL 2337567T3 PL 09788414 T PL09788414 T PL 09788414T PL 09788414 T PL09788414 T PL 09788414T PL 2337567 T3 PL2337567 T3 PL 2337567T3
Authority
PL
Poland
Prior art keywords
veterinary preparation
veterinary
preparation
Prior art date
Application number
PL09788414T
Other languages
English (en)
Inventor
Andrzej Krzysztof Siwicki
Jan Gluszak
Original Assignee
Przed Wielobranzowe Vet Agro Sp Z O O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Przed Wielobranzowe Vet Agro Sp Z O O filed Critical Przed Wielobranzowe Vet Agro Sp Z O O
Publication of PL2337567T3 publication Critical patent/PL2337567T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017Non-human animal skin, e.g. pour-on, spot-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/133Amines having hydroxy groups, e.g. sphingosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A61K31/708Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL09788414T 2008-08-12 2009-08-05 Preparat weterynaryjny PL2337567T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PL385868A PL223158B1 (pl) 2008-08-12 2008-08-12 Zastosowanie metyzoprynolu
EP09788414.2A EP2337567B1 (en) 2008-08-12 2009-08-05 Veterinary preparation
PCT/PL2009/000079 WO2010019059A1 (en) 2008-08-12 2009-08-05 Veterinary preparation

Publications (1)

Publication Number Publication Date
PL2337567T3 true PL2337567T3 (pl) 2015-06-30

Family

ID=41202792

Family Applications (2)

Application Number Title Priority Date Filing Date
PL385868A PL223158B1 (pl) 2008-08-12 2008-08-12 Zastosowanie metyzoprynolu
PL09788414T PL2337567T3 (pl) 2008-08-12 2009-08-05 Preparat weterynaryjny

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL385868A PL223158B1 (pl) 2008-08-12 2008-08-12 Zastosowanie metyzoprynolu

Country Status (3)

Country Link
EP (1) EP2337567B1 (pl)
PL (2) PL223158B1 (pl)
WO (1) WO2010019059A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107158023A (zh) * 2017-04-12 2017-09-15 陈小瑞 防治草鱼和青鱼的病毒性出血病的药物组合物及制备方法
PL425725A1 (pl) * 2018-05-24 2019-12-02 Przed Wielobranzowe Vet Agro Spolka Z Ograniczona Odpowiedzialnoscia Produkt leczniczy zawierający wodny roztwór metyzoprynolu o ulepszonej trwałości
EP4259151A4 (en) * 2020-12-10 2025-01-29 Reena Patel Methisoprinol compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1270832B (it) 1993-09-20 1997-05-13 Luciano Brugola Composizione farmaceutica antivirale contenente la 2-ammino 4,6 dicloropirimidina e metisoprinolo.
WO2003013544A1 (es) * 2001-08-08 2003-02-20 Laboratorios Químicos Industriales, S.A. Medicamento antiviral para utilizarse en el control de la enfermedad mancha blanca en camarones
PL194749B1 (pl) 2001-08-30 2007-06-29 Przed Wielobranzowe Vet Agro S Preparat żelazowy

Also Published As

Publication number Publication date
PL223158B1 (pl) 2016-10-31
EP2337567A1 (en) 2011-06-29
EP2337567B1 (en) 2014-12-31
PL385868A1 (pl) 2010-02-15
WO2010019059A1 (en) 2010-02-18

Similar Documents

Publication Publication Date Title
ZA201006679B (en) Orally-disintergrating solid preparation
GB0815435D0 (en) Formulations
IL211233A0 (en) Vaccine
GB2459691B (en) Formulations
GB0823269D0 (en) Formulations
IL208651A0 (en) Vaccine
GB0822001D0 (en) Vaccine
GB0821789D0 (en) Formulations
GB0810710D0 (en) Vaccine
IL208652A0 (en) Vaccine
EP2307021A4 (en) FORMULATIONS
GB0822633D0 (en) Formulation
GB0816447D0 (en) Vaccine
GB0816284D0 (en) Vaccine
ZA201004772B (en) Novel formulation
GB0814376D0 (en) Formulation
PL2337567T3 (pl) Preparat weterynaryjny
PT2319515E (pt) Combinação coccidiocida para uso veterinário
GB0921378D0 (en) Formulations
GB0916030D0 (en) Formulations
GB0822171D0 (en) Temisartan formulations
GB0811019D0 (en) Odontalgic preparation
GB0823486D0 (en) Formulations
GB0816876D0 (en) Formulations
GB0811447D0 (en) Formulations